Journal profile

ACS chemical neuroscience

Publisher: American Chemical Society
ISSN1948-7193 FormatOnline StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
4.13
Citation rate 4.79 3,771 total citations
h5-index 57 h5 depth signal
Cited share 80.8% 667 of 825
Total citations 3,771 Citation footprint
Metric signal 4.33 External metric anchor
Self-citation 3.0% 114 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 1,244
China 714
India 399
Italy 159
United Kingdom 153

Citing Fields of Research

Neurodegenerative Disorders 1,803
Neurosciences 747
Cellular Membrane Transporters & Receptors 474
Cell Biology 410
Substance Abuse 251

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 5,281 Articles tracked across the journal lifetime
Indexed publication set 825 667 cited publications
Last 12 months 356 29.7 publications/month
Open access share 28.7% 102 OA publications in the last year
Leading citing country United States 1,244 citing publications
Leading citing field Neurodegenerative Disorders 1,803 citing publications
Latest tracked publication 12 November 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1, 2010-
PubMed
v1, 2010-
PMC Inactive
Active Coverage

Research Focus & Classification

Indexed Subjects

Neurodegenerative Disorders

Issuing & Sponsoring Bodies

Contributor
American Chemical Society

Broad Categories

Neurology Neurodegenerative Disorders

MeSH Descriptors

Nervous System Neurosciences

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

03
MatíaS Marambio, ÁlVaro CácEres-Quezada, Nicole Morales-Camilo et al.
Monoamine concentrations in the synaptic cleft are primarily regulated by reuptake through monoamine transporters (MATs) located in presynaptic terminals and axonal membranes. In the serotonin transporter (SERT), the canonical alternatin...
04
Amauri Barbosa Silva Junior, Arnaldo Solheiro Bezerra, AntônIo Wlisses da Silva et al.
Chalcones constitute a relevant class of flavonoids with diverse pharmacological potential, including activity in the central nervous system. In this study, the anxiolytic potential of the chalcone (2E)-1-(4′-aminophenyl)-3-furan-2-yl-pr...
08
Christopher R Greaves, William E Martenis, Shawn D Nelson et al.
Schizophrenia is a debilitating neuropsychiatric disease that lacks effective treatments for many symptom domains including negative, cognitive and sleep disturbances. Lack of clear disease etiology has hampered the development of new, e...

Bibliographical & Catalog Notes

Description based on: Vol. 1, no. 1 (2010); title from journal home page (ACS website, viewed Feb. 4, 2010).